Constitutively active alpha-1b adrenergic receptor mutants display different phosphorylation and internalization...

Area of Science:

• Pharmacology
• Molecular Biology
• Biochemistry

Background:

• The alpha-1b adrenergic receptor (AR) plays a crucial role in various physiological processes.
• Constitutive activity of G protein-coupled receptors (GPCRs) can lead to altered signaling and regulation.
• Understanding receptor domain mutations is key to deciphering GPCR function.

Purpose of the Study:

• To investigate the phosphorylation and internalization of constitutively active alpha-1b AR mutants.
• To compare the effects of mutations in different receptor domains on AR regulation.
• To elucidate the divergent regulatory mechanisms of alpha-1b AR mutants.

Main Methods:

• Site-directed mutagenesis to create alpha-1b AR mutants (A293E, A293I, D142A, D142T).
• Measurement of agonist-independent and GRK2-stimulated phosphorylation.
• Assessment of beta-arrestin interaction and agonist-induced internalization.
• Analysis of a double mutant (A293E/D142A).

Main Results:

• Mutations at A293 increased basal phosphorylation, while D142 mutations did not significantly alter it.
• GRK2 enhanced phosphorylation of A293E but not D142A.
• A293E mutant showed increased beta-arrestin-mediated internalization compared to wild-type.
• D142A mutant exhibited impaired beta-arrestin interaction and internalization.
• The double mutant retained high constitutive activity and combined regulatory properties.

Conclusions:

• Mutations in distinct domains of alpha-1b AR lead to divergent effects on receptor phosphorylation and internalization.
• The A293 mutation impacts basal and GRK2-mediated phosphorylation and enhances internalization.
• The D142 mutation affects agonist-induced internalization and beta-arrestin interaction.
• These findings highlight the complex regulatory mechanisms of constitutively active alpha-1b AR.